Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:1849207.
doi: 10.1155/2016/1849207. Epub 2016 Jan 6.

Comparison of the Mechanical Properties of Early Leukocyte- and Platelet-Rich Fibrin versus PRGF/Endoret Membranes

Affiliations

Comparison of the Mechanical Properties of Early Leukocyte- and Platelet-Rich Fibrin versus PRGF/Endoret Membranes

Hooman Khorshidi et al. Int J Dent. 2016.

Abstract

Objectives. The mechanical properties of membranes are important factors in the success of treatment and clinical handling. The goal of this study was to compare the mechanical properties of early leukocyte- and platelet-rich fibrin (L-PRF) versus PRGF/Endoret membrane. Materials and Methods. In this experimental study, membranes were obtained from 10 healthy male volunteers. After obtaining 20 cc venous blood from each volunteer, 10 cc was used to prepare early L-PRF (group 1) and the rest was used to get a membrane by PRGF-Endoret system (group 2). Tensile loads were applied to specimens using universal testing machine. Tensile strength, stiffness, and toughness of the two groups of membranes were calculated and compared by paired t-test. Results. The mean tensile strength and toughness were higher in group 1 with a significant difference (P < 0.05). The mean stiffness in group 1 was also higher but not statistically significant (P > 0.05). Conclusions. The results showed that early L-PRF membranes had stronger mechanical properties than membranes produced by PRGF-Endoret system. Early L-PRF membranes might have easier clinical handling and could be a more proper scaffold in periodontal regenerative procedures. The real results of the current L-PRF should be in fact much higher than what is reported here.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The dog-bone-shape plexiglass mold.
Figure 2
Figure 2
Tube containing blood in the centrifuge machine.
Figure 3
Figure 3
Tube containing early L-PRF after centrifuge.
Figure 4
Figure 4
Removing the early L-PRF from the tube.
Figure 5
Figure 5
Placing the early L-PRF clot into the mold.
Figure 6
Figure 6
A fibrin specimen in the mold.
Figure 7
Figure 7
A formed specimen.
Figure 8
Figure 8
A BTI kit.
Figure 9
Figure 9
BTI centrifuging machine.
Figure 10
Figure 10
Tubes containing PRGF after centrifuge.
Figure 11
Figure 11
Mixture of the platelet-rich plasma and the activator on the incubator.
Figure 12
Figure 12
A formed specimen.
Figure 13
Figure 13
The universal testing machine.

Similar articles

Cited by

References

    1. Newman M. G., Takei H., Klokkevold P. R., Carranza F. A. Carranza's Clinical Periodontology. Elsevier Health Sciences; 2011.
    1. Boyne P. J., Marx R. E., Nevins M., et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. The International Journal of Periodontics & Restorative Dentistry. 1997;17(1):11–25. - PubMed
    1. Schwartz Z., Carnes D. L., Jr., Pulliam R., et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. Journal of Periodontology. 2000;71(8):1287–1296. doi: 10.1902/jop.2000.71.8.1287. - DOI - PubMed
    1. Marx R. E., Carlson E. R., Eichstaedt R. M., Schimmele S. R., Strauss J. E., Georgeff K. R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 1998;85(6):638–646. doi: 10.1016/s1079-2104(98)90029-4. - DOI - PubMed
    1. Anitua E., Sánchez M., Orive G., Andia I. Delivering growth factors for therapeutics. Trends in Pharmacological Sciences. 2008;29(1):37–41. doi: 10.1016/j.tips.2007.10.010. - DOI - PubMed

LinkOut - more resources